In patients on hemodialysis, Farese et al. report that inhibition of the enzyme 11Β-hydroxysteroid dehydrogenase type 2 by glycyrrhetinic acid, the active compound of licorice, reduces serum potassium concentration and the frequency of hyperkalemia, possibly by enhancing intestinal potassium loss. This finding could be an important tool to maintain predialysis [K ] within safe limits in some dialysis patients at risk of hyperkalemic arrhythmias. © 2009 International Society of Nephrology.
CITATION STYLE
Ferrari, P. (2009). Licorice: A sweet alternative to prevent hyperkalemia in dialysis patients. Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2009.282
Mendeley helps you to discover research relevant for your work.